[18F] - FD17 PET Imaging of α-synuclein: A Clinical Study in α-synucleinopathy Patients
Trial
N/A
Completed
March 4, 2026
Adaptations in Nuclear Neurology Procedures for Elderly Patients: A Survey of Nuclear Medicine Technologists in Portugal.
Research
Journal of nuclear medicine technology
March 4, 2026
Digital Technologies for Symptom Monitoring in Parkinson Disease.
Research
Current neurology and neuroscience reports
March 4, 2026
Advanced Parkinson's disease treatment patterns in Italy: results from a multicenter observational study.
Research
Annals of medicine
March 4, 2026
Kenny is the adaptor protein for ubiquitin-dependent mitophagy in Drosophila melanogaster.
Research
Autophagy reports
March 4, 2026
Effect of Striatal Temporal Interference Stimulation on Language Processing in Neurodegenerative Diseases
Trial
N/A
Recruiting
March 3, 2026
A Late Phase II Clinical Trial of KDT-3594 in Patients With Parkinson's Disease
Trial
Phase 2
Active, not recruiting
March 2, 2026
Udall Project 2 Aim 2A&C
Trial
N/A
Recruiting
March 2, 2026
Sleep-specific DBS Therapy in Parkinson's Disease
Trial
N/A
Recruiting
March 2, 2026
The Effect of Functional Rotational Exercises on Fall Risk and Mobility in Parkinson's Disease Patients
Trial
N/A
Recruiting
March 2, 2026
Parkinson's Disease: Enhancing Physical Therapy With Brain Stimulation for Treating Postural Instability.
Trial
N/A
Active, not recruiting
March 2, 2026
Percept Transitions in FOG and PD
Trial
N/A
Recruiting
March 2, 2026
Gait and Freezing in Parkinson’s
News
Brian Grant Foundation
March 2, 2026
Risk Adjustment for Alzheimer Disease and Related Dementias in Medicare Advantage and Health Care Experiences.
Research
JAMA network open
March 2, 2026
N-acetyl-l-leucine lowers α-synuclein levels and improves synaptic function in Parkinson's disease models.
Research
The Journal of clinical investigation
March 2, 2026
Adrenergic Blockers for Cardiac Changes in Early Parkinson's Disease (Protocol 53136)
Trial
Phase 2
Active, not recruiting
March 1, 2026
Terazosin Effect on Cardiac Changes in Early Parkinson's Disease
Trial
Phase 2
Active, not recruiting
March 1, 2026
Terazosin and Parkinson's Disease Extension Study
Trial
Phase 2
Active, not recruiting
March 1, 2026
Cardiac Changes in Early Parkinson's Disease: A Follow up Study
Trial
Phase 2
Active, not recruiting
March 1, 2026
Effects of rTSMS Associated With Treadmill Training in Patients With Parkinson's Disease
Trial
N/A
Completed
March 1, 2026